Team:Freiburg/Content/Results/Summary
From 2014.igem.org
Line 66: | Line 66: | ||
<div> | <div> | ||
- | + | ||
- | + | <p> We, the iGEM Team Freiburg 2014, have the goal to combine the capability of viral vectors for stable gene transfer with the spatio-temporal resolution of optogenetics for gene delivery into mammalian cells. We utilized the Murine Leukemia Virus (MuLV) that specifically uses the murine mCAT-1 receptor to infect target cells. By using a blue light inducible expression system, we brought the receptor to the plasma membrane of illuminated cells to enable targeted gene delivery by the virus. | |
- | + | </p> | |
- | + | ||
- | <p> We | + | <p> |
+ | Our project was quite a large success! We: | ||
+ | </p> | ||
+ | <ul> | ||
+ | <li>produced MuLV viruses containing different reporter proteins,</li> | ||
+ | <li>optimized MuLV production and transduction protocols to reach close to 100% efficiency,</li> | ||
+ | <li>created stable mammalian cell lines using the MuLV virus,</li> | ||
+ | <li>generated patterns of reporter proteins in cell cultures by light exposure,</li> | ||
+ | <li>demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,</li> | ||
+ | <li>infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.</li> | ||
+ | </ul> | ||
+ | |||
+ | <p> | ||
+ | We provide the virus as a tool for the generation of stable mammalian cell lines under biosafety level 1 regulations. Our viral vector, which we propose as a new iGEM RFC, enables the user to introduce any gene of interest stably into mammalian cell lines. Therefore we provide for the iGEM community a fast, easy to handle and safe way of generating stable cell lines. | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | During the course of iGEM, we learned many new techniques: | ||
+ | </p> | ||
+ | |||
+ | <ul> | ||
+ | <li>mammalian cell culture,</li> | ||
+ | <li>fluorescence activated cell sorting,</li> | ||
+ | <li>virus production under biosafety level 1 and biosafety level 2 conditions,</li> | ||
+ | <li>many different cloning techniques,</li> | ||
+ | <li>widefield and confocal microscopy,</li> | ||
+ | <li>creating a website,</li> | ||
+ | </ul> | ||
+ | |||
+ | <p> | ||
+ | and, last but not least, we had a lot of fun and learned how to work together as a team! | ||
+ | </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
<div> | <div> | ||
- | + | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
</section> | </section> | ||
<div class="row category-row"> | <div class="row category-row"> |
Revision as of 03:23, 18 October 2014
Summary
We, the iGEM Team Freiburg 2014, have the goal to combine the capability of viral vectors for stable gene transfer with the spatio-temporal resolution of optogenetics for gene delivery into mammalian cells. We utilized the Murine Leukemia Virus (MuLV) that specifically uses the murine mCAT-1 receptor to infect target cells. By using a blue light inducible expression system, we brought the receptor to the plasma membrane of illuminated cells to enable targeted gene delivery by the virus.
Our project was quite a large success! We:
- produced MuLV viruses containing different reporter proteins,
- optimized MuLV production and transduction protocols to reach close to 100% efficiency,
- created stable mammalian cell lines using the MuLV virus,
- generated patterns of reporter proteins in cell cultures by light exposure,
- demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,
- infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.
We provide the virus as a tool for the generation of stable mammalian cell lines under biosafety level 1 regulations. Our viral vector, which we propose as a new iGEM RFC, enables the user to introduce any gene of interest stably into mammalian cell lines. Therefore we provide for the iGEM community a fast, easy to handle and safe way of generating stable cell lines.
During the course of iGEM, we learned many new techniques:
- mammalian cell culture,
- fluorescence activated cell sorting,
- virus production under biosafety level 1 and biosafety level 2 conditions,
- many different cloning techniques,
- widefield and confocal microscopy,
- creating a website,
and, last but not least, we had a lot of fun and learned how to work together as a team!